Filing Details
- Accession Number:
- 0000899243-20-034688
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-21 16:05:07
- Reporting Period:
- 2020-12-18
- Accepted Time:
- 2020-12-21 16:05:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1214133 | H Richard Scheller | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-18 | 27,105 | $64.99 | 109,156 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-18 | 2,895 | $65.78 | 106,261 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold from $64.67 to $65.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securuity holder of the Issuer, full information regarding the number of share sold at each separate price for all transactions as reported in footnotes 1 and 2.
- Represents the weighted average sale price of the shares sold from $65.685 to $65.95 per share.